PDCD1 and nasopharyngeal carcinoma: Makowska et al. found that PD-1 blockade increased cytotoxicity of IFNβ-activated NK cells toward nasopharyngeal carcinoma cells, which resulted from the secretion of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) (77).